文献速递心律失常心力衰竭与心肌病

左心室功能障碍与心房颤动中K2P3.1钾通道表达及动作电位时程的逆向重构:对患者特异性抗心律失常药物治疗的意义

Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
PubMed 文献 · Eur Heart J · 2017-01-01

研究纳入175例不同阶段左心室功能障碍患者,检测心房K2P3.1表达与动作电位。严重左室功能减退伴窦性心律者K2P3.1表达降低,慢性房颤者升高,阵发性房颤无显著重构;K2P3.1抑制在慢性房颤中缩短动作电位时程的作用不受左室功能影响,而在严重左室功能减退的阵发性房颤患者中导致动作电位时程过度延长。

要点

  • 严重左室功能减退伴窦性心律者心房K2P3.1表达降低,慢性房颤者升高。
  • 左室功能障碍相关K2P3.1电流抑制延长心房动作电位时程。
  • K2P3.1抑制在严重左室功能减退的阵发性房颤患者中导致动作电位时程过度延长。

核心结论

  • 左室功能障碍与心房K2P3.1通道表达降低相关,而慢性房颤导致K2P3.1丰度增加,K2P3.1与动作电位时程的差异重构为患者量身定制抗心律失常策略提供了基础。

研究设计与样本

  • 共纳入175例不同阶段左心室功能障碍患者,采用实时聚合酶链反应和蛋白质印迹定量离子通道表达,并用膜片钳技术记录心房心肌细胞膜电流和动作电位。

主要发现

  • 严重左室功能减退的窦性心律患者心房K2P3.1表达降低,而慢性房颤患者K2P3.1水平升高,阵发性房颤与显著K2P3.1重构无关。
  • 左室功能障碍相关K2P3.1电流抑制使心房动作电位时程较左室功能保留患者延长。
  • 在合并左室功能障碍与慢性房颤的个体中,动作电位时程分别由左室功能障碍相关延长和慢性房颤依赖的缩短决定,与K2P3.1丰度变化一致。
  • K2P3.1抑制减弱慢性房颤患者的动作电位时程缩短,与左室功能无关;而在左室功能严重减退的阵发性房颤受试者中,K2P3.1阻断导致动作电位时程过度延长。

临床怎么用

  • 作者认为,K2P3.1与动作电位时程的差异重构为患者量身定制抗心律失常策略提供了基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Atrial fibrillation (AF) prevalence increases with advanced stages of left ventricular (LV) dysfunction. Remote proarrhythmic effects of ventricular dysfunction on atrial electrophysiology remain incompletely understood. We hypothesized that repolarizing K2P3.1 K+ channels, previously implicated in AF pathophysiology, may contribute to shaping the atrial action potential (AP), forming a specific electrical substrate with LV dysfunction that might represent a target for personalized antiarrhythmic therapy. METHODS AND RESULTS: A total of 175 patients exhibiting different stages of LV dysfunction were included. Ion channel expression was quantified by real-time polymerase chain reaction and Western blot. Membrane currents and APs were recorded from atrial cardiomyocytes using the patch-clamp technique. Severely reduced LV function was associated with decreased atrial K2P3.1 expression in sinus rhythm patients. In contrast, chronic (c)AF resulted in increased K2P3.1 levels, but paroxysmal (p)AF was not linked to significant K2P3.1 remodelling. LV dysfunction-related suppression of K2P3.1 currents prolonged atrial AP duration (APD) compared with patients with preserved LV function. In individuals with concomitant LV dysfunction and cAF, APD was determined by LV dysfunction-associated prolongation and by cAF-dependent shortening, respectively, consistent with changes in K2P3.1 abundance. K2P3.1 inhibition attenuated APD shortening in cAF patients irrespective of LV function, whereas in pAF subjects with severely reduced LV function, K2P3.1 blockade resulted in disproportionately high APD prolongation. CONCLUSION: LV dysfunction is associated with reduction of atrial K2P3.1 channel expression, while cAF leads to increased K2P3.1 abundance. Differential remodelling of K2P3.1 and APD provides a basis for patient-tailored antiarrhythmic strategies.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Schmidt C, Wiedmann F, Zhou XB, et al. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy. Eur Heart J. 2017. PMID: 28057773. doi:10.1093/eurheartj/ehw559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。